![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SCHATZ & NOBEL, P.C. ANNOUNCES CLASS ACTION LAWSUIT AGAINST CONNETICS CORPORATION
SCHATZ & NOBEL, P.C. ANNOUNCES CLASS ACTION LAWSUIT AGAINST CONNETICS CORPORATION
September 21, 2006
The law firm of Schatz & Nobel, P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Northern District of California on behalf of all persons who purchased the publicly traded securities of Connetics Corporation (the Company'') between June 28, 2004 and May 3, 2006, inclusive, (the Class Period''). Yahoo Finance (http://biz.yahoo.com/pz/060920/105532.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct